Mpmri of the Prostate in Patients Carrying a High Clinical Risk of Prostate Cancer Diagnosis: is This Imaging Test Necessary for Diagnostic Purposes in This Subset of Patients?
Armando Stabile,Giorgio Gandaglia,Francesco Pellegrino,Vito Cucchiara,Elio Mazzone,Nicola Fossati,Marco Moschini,Agostino Mattei,Luca Afferi,Sergio Serni,Andrea Minervini,Razvan-George Rahota,Guillaume Ploussard,Massimo Valerio,Jean Baptiste Beavaul,Alessandro Marquis,Arnas Rakauskas,Paolo Gontero,Hongqian Guo,Junlong Zhuang,Roderick Van den Bergh,Timo Soeterik,Francesco Montorsi,Alberto Briganti
DOI: https://doi.org/10.1016/s0302-2838(23)00146-x
IF: 7.6
2023-01-01
The Journal of Urology
Abstract:You have accessJournal of UrologyCME1 Apr 2023PD39-04 MPMRI OF THE PROSTATE IN PATIENTS CARRYING A HIGH CLINICAL RISK OF PROSTATE CANCER DIAGNOSIS: IS THIS IMAGING TEST NECESSARY FOR DIAGNOSTIC PURPOSES IN THIS SUBSET OF PATIENTS? Armando Stabile, Giorgio Gandaglia, Francesco Pellegrino, Vito Cucchiara, Elio Mazzone, Nicola Fossati, Marco Moschini, Agostino Mattei, Luca Afferi, Sergio Serni, Andrea Minervini, Razvan-George Rahota, Guillaume Ploussard, Massimo Valerio, Jean Baptiste Beavaul, Alessandro Marquis, Arnas Rakauskas, Paolo Gontero, Hongqian Guo, Junlong Zhuang, Roderick Van Den Bergh, Timo Soeterik, Francesco Montorsi, and Alberto Briganti Armando StabileArmando Stabile More articles by this author , Giorgio GandagliaGiorgio Gandaglia More articles by this author , Francesco PellegrinoFrancesco Pellegrino More articles by this author , Vito CucchiaraVito Cucchiara More articles by this author , Elio MazzoneElio Mazzone More articles by this author , Nicola FossatiNicola Fossati More articles by this author , Marco MoschiniMarco Moschini More articles by this author , Agostino MatteiAgostino Mattei More articles by this author , Luca AfferiLuca Afferi More articles by this author , Sergio SerniSergio Serni More articles by this author , Andrea MinerviniAndrea Minervini More articles by this author , Razvan-George RahotaRazvan-George Rahota More articles by this author , Guillaume PloussardGuillaume Ploussard More articles by this author , Massimo ValerioMassimo Valerio More articles by this author , Jean Baptiste BeavaulJean Baptiste Beavaul More articles by this author , Alessandro MarquisAlessandro Marquis More articles by this author , Arnas RakauskasArnas Rakauskas More articles by this author , Paolo GonteroPaolo Gontero More articles by this author , Hongqian GuoHongqian Guo More articles by this author , Junlong ZhuangJunlong Zhuang More articles by this author , Roderick Van Den BerghRoderick Van Den Bergh More articles by this author , Timo SoeterikTimo Soeterik More articles by this author , Francesco MontorsiFrancesco Montorsi More articles by this author , and Alberto BrigantiAlberto Briganti More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003342.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: mpMRI and subsequent targeted biopsy (TBx) significantly increases the detection of clinically significant prostate cancer (csPCa). However, its diagnostic benefit in men with a high clinical risk of PCa remains controversial. We hypothesised that not all patients with a clinical suspicion of PCa may benefit from mpMRI for diagnostic purposes. Specifically, the added value of TBx in patients with high risk of having CSPCa may be negligible. METHODS: We identified 3,639 patients with clinical suspicion of PCa and suspicious mpMRI (PI-RADS≥3) that received a SBx + TBx at 10 referral centres between 2014-2022. We then compared the detection of csPCa between SBx and TBx, according to the individual patient risk of having csPCa in order to assess the added benefit of TBx over SBx. We used a multivariable logistic regression analysis (MVA) to predict the risk of csPCa at prostate biopsy relying on clinical and radiological characteristics such as age, PSA, digital rectal examination, and PI-RADS. We then used loess non-parametric analysis to graphically explore the probability of csPCa at TBx vs SBx according to the pre-test probability of csPCa diagnosis calculated at MVA, hence comparing the diagnostic benefit related to each biopsy technique in terms of csPCa detection. RESULTS: 1,491 (41%) patients had positive DRE and>86% had a PI-RADS 4-5 lesion at mpMRI. The median number of total and TBx cores taken was 14 and 4, respectively. csPCa incidence was 80%. Figure 1 shows the variation of csPCa detection of TBx vs SBx according to individual risk of having csPCa. The detection of csPCa in TBx vs SBx ranged from 15% vs 30% (p<0.001) to 80% vs 81% (p=0.3), for patients with very-low and very-high risk of having csPCa, respectively. The diagnostic benefit of adding TBx to SBx was highest in men with low risk of having csPCa (delta=15%). Conversely, in men with a risk higher than 60%, csPCa detection in TBx vs SBx were similar. CONCLUSIONS: The added benefit of TBx to SBx in men with suspicion of PCa and concomitant positive mpMRI is highest in patients with low-intermediate risk of harboring csPCa. In patients with high clinical risk of having csPCa, adding TBx was not informative. The use of mpMRI in patients at high risk of csPCa is questionable for diagnostic purposes. Source of Funding: NA © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1045 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Armando Stabile More articles by this author Giorgio Gandaglia More articles by this author Francesco Pellegrino More articles by this author Vito Cucchiara More articles by this author Elio Mazzone More articles by this author Nicola Fossati More articles by this author Marco Moschini More articles by this author Agostino Mattei More articles by this author Luca Afferi More articles by this author Sergio Serni More articles by this author Andrea Minervini More articles by this author Razvan-George Rahota More articles by this author Guillaume Ploussard More articles by this author Massimo Valerio More articles by this author Jean Baptiste Beavaul More articles by this author Alessandro Marquis More articles by this author Arnas Rakauskas More articles by this author Paolo Gontero More articles by this author Hongqian Guo More articles by this author Junlong Zhuang More articles by this author Roderick Van Den Bergh More articles by this author Timo Soeterik More articles by this author Francesco Montorsi More articles by this author Alberto Briganti More articles by this author Expand All Advertisement PDF downloadLoading ...